BeWell Health will debut its doctorgram Telehealth System at the 2025 Healthcare Expo Taiwan, introducing an integrated tele-monitoring and tele-visit solution designed to enhance the efficiency and quality of home healthcare. In response to Taiwan government “Health For All In Taiwan” initiative and the growing demand for aging-related care, doctorgram provides a streamlined platform that supports real-time physiological data monitoring, guided symptom reporting, and seamless teleconsultations.

The system adopts a closed-loop service model that enables healthcare institutions to establish virtual clinics or dedicated digital wards, ensuring consistent care delivery and secure patient management across settings. All data storage and processing follow international-grade information security standards, complying with U.S. HIPAA regulations and certified under ISO27001 and ISO27701 to safeguard patient privacy and sensitive health information.

At the Healthcare Expo, BeWell Health will showcase doctorgram's full range of applications, demonstrating how the platform integrates health data, supports remote monitoring, and facilitates long-term care management to strengthen doctor–patient interaction and overcome geographic barriers. Visitors are invited to experience the future of digital health and home-based medical care at TaiNEX 1, 4F, Booth N003.

This product integrates fluorescence detection technology with edge computing and advanced image processing algorithms to deliver real-time feedback and quantitative evaluation of hand hygiene performance. It helps healthcare facilities improve compliance rates, reduce the risk of healthcare-associated infections, and strengthen infection control strategies.

BellWishes is set to make a significant impact at the 2025 Taiwan Healthcare Expo, unveiling its core product lines centered around the theme of "Foundational Health." The spotlight will be on five key products: "Lutein," "Premium Taiwanese Green Propolis," "Beauty Collagen Peptide," "High-Concentration EPA Fish Oil," and the new "Longevity" series. The exhibition will demonstrate how scientific evidence and innovative formulations can integrate professional-grade nutrition into daily life, building a robust health defense network for every family member.

EZ Caring PX combines visual recognition and functional movement screen (FMS) to assess muscular capability and functional performance. Through AI-driven algorithms for data analysis and health evaluation, it can instantly generate personalized test results.

Vision ReNu Corp. is dedicated to advancing global brain health through innovative, clinician-centered medical technologies. In response to the growing global burden of depression and neurological disorders, the company has developed Taiwan’s first transcranial magnetic stimulation system specifically designed for depressive disorder treatment — MagRenu™ TMS, which received regulatory approval from the Taiwan Food and Drug Administration (TFDA, Registration No. 008433) in 2025.
MagRenu™ TMS utilizes high-density pulsed magnetic field technology and supports advanced, customizable stimulation protocols, including rTMS, iTBS, and open-parameter individualized treatment modes. This non-invasive and safe neuromodulation platform enables precise, reliable, and reproducible stimulation of targeted neural circuits, improving clinical efficiency and therapeutic outcomes.
The system is designed primarily for adult patients with Major Depressive Disorder (MDD) who have an inadequate response to conventional pharmacological treatments. In addition, TMS technology has been widely investigated for applications in insomnia, mild cognitive impairment, dementia, Alzheimer’s disease, Parkinson’s disease, and other neurological and neuropsychiatric conditions, positioning MagRenu™ TMS as a versatile platform for both clinical and research use.
Compared with costly imported alternatives, MagRenu™ TMS offers high-quality performance, competitive pricing, and flexible system architecture, significantly lowering the barrier for hospitals and clinics to adopt advanced neurostimulation services. Driven by the mission of “Safeguarding Brain Health Through Technology,” Vision ReNu Corp. is committed to providing safe, effective, and accessible neuromodulation solutions to improve patient outcomes and reduce the societal burden of neurological and psychiatric disorders.

TAIWANYTG introduces its Nano-Tech Film Patch, a next-generation solution featuring ultra-thin, breathable and low-allergy nano film technology. Awarded SNQ and iENA Gold, the series includes Nano Film Patch, Warming UP Film Patch and Pain Fast Spray for advanced, future-ready relief.

The showcased AI 3D Body Management System utilizes non-contact scanning to record body contour changes accurately and, through AI data analysis, provides personalized posture insights and product recommendations.
This technology supports a wide range of applications, including post-mastectomy rehabilitation, postpartum body recovery, and posture correction, helping women better understand their bodies in a scientific, safe, and data-driven way—leading to healthier, more confident choices in supportive and wellness garments.

The 2025 Healthcare+ Expo Taiwan is set to feature a new "Ageless Zone" (無齡專區). ProGuard BioMed Co., Ltd. is officially launching its presence at the expo, adopting the theme: "Comprehensive Protection: Building a New Future of Health." The company will be debuting its products in collaboration with Coarse Taste Lifestyle (粗味生活).
ProGuard BioMed was established by an interdisciplinary team from the NCCU EMBA Biomedical Platform, integrating expertise in nutrition, medicine, and the biotech industry. The company is dedicated to developing functional health supplements that are clinically validated, safe, and effective.
Its brand, ProGuard, uses the "shield" as a symbol of defending health. The product line offers personalized health protection solutions for modern individuals, covering four key areas:
Men's Protection
Sleep & Brain Health
Women's Beauty & Vitality
Joint & Mobility Support
At this year's expo, the combination of ProGuard's offerings and Coarse Taste's "Good Times" aims to ensure that customers "are full of vitality every day."

This groundbreaking technology is the world’s first AI-powered dynamic ultrasound system for shoulder joint analysis. It captures real-time motion of the acromion and greater tuberosity during shoulder activity and uses deep learning to quantify the risk of subacromial impingement syndrome. Unlike traditional static and subjective assessments, this system offers objective, fast, and visualized diagnostic support. Designed for physical medicine and orthopedic use, it integrates with self-paid injection therapies and rehabilitation, delivering dual clinical and commercial value for the management of common shoulder pain conditions.

[b]Genicore leverages its leading Genimer™ Aptamer Screening Technology Platform to offer custom services.[/b] Due to the aptamer's small molecule structure, high affinity, and superior manufacturing stability, this technology effectively overcomes the cost and time limitations associated with traditional antibodies.
[b]At the exhibition, we are launching several innovative tools:
1. His-Tag Protein Capture Kit:[/b]
Utilizes Genimer™ probes to achieve ultra-high specificity capture.
Delivers ultra-high-purity proteins with no metal or chemical residues, making it perfectly suitable for sensitive downstream analyses (such as mass spectrometry).
[b]2. Complete Exosome Solution:
Product 1 - CD63 Exosome Capture Kit:[/b] Ensures the complete structure and functionality of exosomes through gentle elution, achieving a [b]2.5-fold increase in capture efficiency[/b] compared to traditional affinity methods.
[b]Product 2 - CD9 & CD63 Exosome Detection Kit:[/b] Features a sensitivity [b]hundreds of times higher[/b] than competing products, allowing for the precise quantification of exosomes using extremely small sample volumes.
[b]Genimer™ technology is being widely applied across medical diagnostics and regenerative medicine.[/b] Genicore invites the industry to collaborate and forge a new future for biotechnology.

At the 2025 Healthcare Expo Taiwan, Lis Tech will present a portfolio of cutting-edge solutions focusing on 3D cell culture, 3D bioprinting, and exosome purification technologies. Representing Sumitomo Bakelite’s Sbio™ series, the showcase will include PrimeSurface™ 3D cell culture plates and the BioStellar™ organoid culture platform. In addition, Lis Tech will feature the 3D bioprinters from Korea’s ROKIT Healthcare, highlighting the integration of AI with 3D bioprinting in regenerative medicine to advance from 2D culture toward a true in vivo–like environment. Meanwhile, GeniCore Biotech will highlight its Genimer™ platform, offering highly sensitive exosome detection and purification tools to support researchers in exosome studies. Lis Tech is committed to integrating global innovations to accelerate Taiwan’s path toward regenerative and precision medicine.